Literature DB >> 3410548

Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor.

Y Shemer-Avni1, D Wallach, I Sarov.   

Abstract

Purified human recombinant tumor necrosis factor (rTNF) alpha inhibited the growth of Chlamydia trachomatis (L2/434/Bu) in HEp-2 cell cultures. The inhibition of C. trachomatis yield could be achieved even when the rTNF alpha (200 ng/ml) was added up to 12 h after infection. The effect of rTNF alpha on chlamydial infection was synergistic with that of gamma interferon.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3410548      PMCID： PMC259596          DOI： 10.1128/iai.56.9.2503-2506.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  25 in total

1.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

2.  [3H]Uridine uptake by target monolayers as a terminal label in an in vitro cell-mediated cytotoxicity assay.

Authors:  G Smith; S Nicklin
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

3.  Chlamydia trachomatis serology in ankylosing spondylitis.

Authors:  P A Csángó; M T Upsahl; O Romberg; L Kornstad; I Sarov
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

4.  Physicochemical characterization of cytostatic factors released from human monocytes.

Authors:  J Nissen-Meyer; J Hammerstrøm
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

5.  Proliferative human T cell responses to Chlamydia trachomatis in vitro.

Authors:  E Qvigstad; K Skaug; E Thorsby
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1983-06

6.  Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.

Authors:  B D Williamson; E A Carswell; B Y Rubin; J S Prendergast; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans.

Authors:  R C Brunham; D H Martin; C C Kuo; S P Wang; C E Stevens; T Hubbard; K K Holmes
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Human cell-mediated immune responses to chlamydial antigens.

Authors:  L Hanna; L Schmidt; M Sharp; D P Stites; E Jawetz
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  Lymphokine enhances oxygen-independent activity against intracellular pathogens.

Authors:  H W Murray; G I Byrne; C D Rothermel; D M Cartelli
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

10.  Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin.

Authors:  D S Stone-Wolff; Y K Yip; H C Kelker; J Le; D Henriksen-Destefano; B Y Rubin; E Rinderknecht; B B Aggarwal; J Vilcek
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307
View more
  51 in total

1.  Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway.

Authors:  I P Cerávolo; A C Chaves; C A Bonjardim; D Sibley; A J Romanha; R T Gazzinelli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Gamma interferon and interleukin-10 gene expression in synovial tissues from patients with early stages of Chlamydia-associated arthritis and undifferentiated oligoarthritis and from healthy volunteers.

Authors:  S Kotake; H R Schumacher; T K Arayssi; H C Gérard; P J Branigan; A P Hudson; C H Yarboro; J H Klippel; R L Wilder
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 3.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

4.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

5.  Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Beyond Tryptophan Synthase: Identification of Genes That Contribute to Chlamydia trachomatis Survival during Gamma Interferon-Induced Persistence and Reactivation.

Authors:  Matthew K Muramatsu; Julie A Brothwell; Barry D Stein; Timothy E Putman; Daniel D Rockey; David E Nelson
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 7.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 8.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

9.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

10.  Serovar-specific immune responses to peptides of variable regions of Chlamydia trachomatis major outer membrane protein in serovar D-infected women.

Authors:  Pragya Srivastava; Rishein Gupta; Hem Chandra Jha; Rajneesh Jha; Apurb Rashmi Bhengraj; Sudha Salhan; Aruna Mittal
Journal:  Clin Exp Med       Date:  2008-09-25       Impact factor: 3.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.